Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

Compounds for Cancer Therapy


Detailed Technology Description

These compounds are potent inhibitors of the isoenzyme PFKFB3,which is over-expressed to enhance glycolysis in most cancer cells. These newlyidentified inhibitors selectively bind to PFKFB3, reduce the Fru-2,6-BP levelsand glycolytic flux, resulting not only in growth inhibition of tumor cells butalso massive cell death.  The compoundscan be administered to a patient by any suitable means, including intravenous,parenteral, subcutaneous, intrapulmonary, and intranasal administration.


Countries

United States


Application No.

13/467,764


Country/Region

USA

For more information, please click Here
Business of IP Asia Forum
Desktop View